#BPIConf: Six Insights on BioProcess Manufacturing Innovation

On the first day of BioProcess International, we were able to sit in on 3M™'s full day symposium Innovation through Integrated Process Development.

Here were our six of our take aways:

• 1. Rob Piper, Principal Scientist, Amgen on the strengths of using disposables: low investment, small footprint, single/quick expression, short implementation time, reduced qualification/maintenance and fast passed product of change
• 2. According to Abhinav Shukla, Ph.D., of KBI Biopharma, mixed mode chormotography: examine and incorporate modulators into process that can help increase selectivity and purity of a product.
• 3. Kumar Dhanasekharan, Director of Process Development of Cook Pharmica emphasized that continuity in process development as should be developed and scaled as production occurs through the different phases.
• 4. 3M recently conducted the web seminar 3M™ Innovation: Transforming and Redefining Biopharmaceutical Purification with 3M™ Emphaze™ AEX Hybrid Purifier – which was discussed throughout the day in the track. See the web seminar here.
• 5. Rahul Singhvi, Ph.D, MSc., COO, Global Vaccines Business Unite, Takeda Pharmaceuticals brought a different perspective to the table. He challenged production innovators to take a new approach to manufacturing tried and true vaccines the access to childhood vaccines is not reliable, accessible or affordable enough.
• 6. Holistic approach to biopharmaceutical development – this should lead to a higher performances with lower cost of manufacturing processes.

Stay tuned to #BPIConf to follow along with today's events and check back for more highlight posts throughout the event!

Share this article with your social network, just click below to share now!

Share |